These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 21460715)
1. Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management. Vultaggio A; Maggi E; Matucci A Curr Opin Allergy Clin Immunol; 2011 Jun; 11(3):262-8. PubMed ID: 21460715 [TBL] [Abstract][Full Text] [Related]
2. Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies. Hong DI; Bankova L; Cahill KN; Kyin T; Castells MC Expert Rev Clin Immunol; 2012 Jan; 8(1):43-52; quiz 53-4. PubMed ID: 22149339 [TBL] [Abstract][Full Text] [Related]
3. The complex clinical picture of side effects to biologicals. Hausmann OV; Seitz M; Villiger PM; Pichler WJ Med Clin North Am; 2010 Jul; 94(4):791-804, xi-ii. PubMed ID: 20609863 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of adverse drug reactions to biologics. Clarke JB Handb Exp Pharmacol; 2010; (196):453-74. PubMed ID: 20020272 [TBL] [Abstract][Full Text] [Related]
9. Anaphylaxis to chemotherapy and monoclonal antibodies. Castells MC Immunol Allergy Clin North Am; 2015 May; 35(2):335-48. PubMed ID: 25841555 [TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization. Castells M; Sancho-Serra Mdel C; Simarro M Cancer Immunol Immunother; 2012 Sep; 61(9):1575-84. PubMed ID: 22576054 [TBL] [Abstract][Full Text] [Related]
11. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy. Chung CH Oncologist; 2008 Jun; 13(6):725-32. PubMed ID: 18586928 [TBL] [Abstract][Full Text] [Related]
12. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection. Belchi-Hernandez J; Espinosa-Parra FJ Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118 [TBL] [Abstract][Full Text] [Related]
13. Management and preparedness for infusion and hypersensitivity reactions. Lenz HJ Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249 [TBL] [Abstract][Full Text] [Related]
14. Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies. Picard M; Galvão VR J Allergy Clin Immunol Pract; 2017; 5(3):600-609. PubMed ID: 28110056 [TBL] [Abstract][Full Text] [Related]
15. Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer--identification, prevention, and management. Kang SP; Saif MW J Support Oncol; 2007 Oct; 5(9):451-7. PubMed ID: 18019853 [No Abstract] [Full Text] [Related]
16. [Management and choice of antibiotics for patients with an allergy to penicillin]. Rijnders BJ; Ceuppens JL; Peetermans WE Ned Tijdschr Geneeskd; 1999 Feb; 143(7):336-41. PubMed ID: 10221094 [TBL] [Abstract][Full Text] [Related]